TP53 and cancer: On the other hand, the Asian Cancer Research Group (ACRG) focused on gene expression profiles and classified gastric cancer into four subtypes with distinct clinical outcomes: microsatellite stable (MSS), epithelial-mesenchymal transition (EMT), MSI, MSS/p53 active and MSS/p53 inactive.